ABT: Abbott Laboratories insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
2,992 institutions reported holding $120.96B of Abbott Laboratories on Form 13F (3,119 the quarter before). 154 opened a new position and 280 sold out. Shares held by institutions: same.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 152,563,476 | $13.84B |
| VANGUARD CAPITAL MANAGEMENT LLC | 113,750,994 | $10.32B |
| STATE STREET CORP | 80,926,234 | $7.34B |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 59,674,507 | $5.41B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 49,017,866 | $4.45B |
| GEODE CAPITAL MANAGEMENT, LLC | 39,219,337 | $3.54B |
| Capital Research Global Investors | 36,908,990 | $3.35B |
| Capital International Investors | 34,654,113 | $3.15B |
| MORGAN STANLEY | 26,611,315 | $2.41B |
| NORGES BANK | 23,354,911 | $2.12B |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.